$2.89
-0.09 (-3.02%)
Open$3.04
Previous Close$2.98
Day High$3.32
Day Low$2.85
52W High$27.20
52W Low$2.80
Volume—
Avg Volume430.2K
Market Cap67.11M
P/E Ratio—
EPS$-65.26
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 35.77M | 36.63M | 30.48M |
| Net Income | -8,575,403 | -9,331,208 | -6,103,234 |
| Profit Margin | -24.0% | -25.5% | -20.0% |
| EBITDA | -11,561,063 | -12,252,085 | -10,099,093 |
| Free Cash Flow | -5,624,875 | -5,815,077 | -3,826,455 |
| Rev Growth | +23.1% | +18.9% | +13.6% |
| Debt/Equity | 0.47 | 0.46 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |